Neumora Therapeutics, Inc. (NMRA)

Neumora Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	129.07	142.15	374.04	240.94	409.25	191.98
Short-Term Investments	42.45	165.43	79.94	130.94	-	-
Cash & Short-Term Investments	171.53	307.58	453.98	371.88	409.25	191.98
Cash Growth	-49.74%	-32.25%	22.08%	-9.13%	113.17%	-
Other Receivables	-	-	-	0.92	0.2	0.15
Receivables	-	-	-	0.92	0.2	0.15
Prepaid Expenses	5.56	5.26	18	1.62	1.2	0.78
Restricted Cash	-	1.21	-	0.05	0.13	0.13
Other Current Assets	-	-	6.3	13.48	4.84	0.81
Total Current Assets	177.08	314.06	478.28	387.96	415.6	193.84
Property, Plant & Equipment	0.55	2.92	6.86	10.64	4.04	3.92
Long-Term Investments	-	-	9.85	23.51	-	-
Long-Term Deferred Charges	-	-	-	2.9	1.83	-
Other Long-Term Assets	0.2	-	1.21	1.23	7.82	0.18
Total Assets	177.83	316.97	496.2	426.23	429.3	197.95
Accounts Payable	0.55	3.31	0.34	7.15	1.64	2.4
Accrued Expenses	24.98	24.59	21.26	11.54	19.1	5.6
Current Portion of Leases	0.26	1.85	3.38	3.37	1.06	0.76
Other Current Liabilities	0.06	0.13	0.14	1.64	1.49	0.61
Total Current Liabilities	25.84	29.89	25.11	23.7	23.28	9.37
Long-Term Leases	0.27	-	1.85	5.07	1	1.28
Other Long-Term Liabilities	-	0.02	0.16	0.63	0.39	-
Total Liabilities	45.67	29.91	27.12	29.4	24.66	10.65
Common Stock	0.02	0.02	0.02	0	0.01	0.01
Additional Paid-In Capital	1,257	1,234	1,173	21.43	11.37	4.9
Retained Earnings	-1,125	-947.22	-703.43	-467.51	-336.61	-99.29
Comprehensive Income & Other	0.01	0.06	-0.08	-0.77	-	-
Total Common Equity	132.16	287.06	469.08	-446.85	-325.22	-94.38
Shareholders' Equity	132.16	287.06	469.08	396.84	404.64	187.3
Total Liabilities & Equity	177.83	316.97	496.2	426.23	429.3	197.95
Total Debt	20.09	1.85	5.23	8.44	2.05	2.05
Net Cash (Debt)	151.44	305.73	458.6	386.95	407.2	189.93
Net Cash Growth	-55.27%	-33.34%	18.52%	-4.97%	114.39%	-
Net Cash Per Share	0.94	1.92	7.05	14.22	18.60	14.61
Filing Date Shares Outstanding	167.09	161.98	158.89	32.61	31.98	30.61
Total Common Shares Outstanding	161.95	161.71	158.83	32.61	31.98	30.61
Working Capital	151.24	284.17	453.17	364.26	392.33	184.47
Book Value Per Share	0.82	1.78	2.95	-13.70	-10.17	-3.08
Tangible Book Value	132.16	287.06	469.08	-446.85	-325.22	-94.38
Tangible Book Value Per Share	0.82	1.78	2.95	-13.70	-10.17	-3.08
Machinery	-	3.19	3.18	2.94	2.3	1.83
Construction In Progress	-	-	0.04	0.51	0.22	-
Leasehold Improvements	-	-	-	0.02	0.26	0.21

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q